PharmaCyte Biotech increases stake in TNF Pharmaceuticals by $3M

PharmaCyte Biotech (PMCB) announced that it has increased its stake in TNF Pharmaceuticals (TNFA) by an additional $3M. The company does so to help support TNF’s recent acquisition of a license with LightSolver. The license is for its revolutionary processing accelerator designed to expedite compute-sensitive computations by harnessing light for computation. This method is designed to reduce energy output by 90% while outpacing conventional graphics processing units, quantum computing and high-performance computing with greater speed and more efficiency. TNF is expected to change its name and ticker symbol to support the new strategy, which it expects to be applied to cryptocurrency mining and blockchain.